started · updated
GLP-1 medications linked to nail and hair side effects
International research studies have identified potential new side effects associated with GLP-1 receptor agonists, such as Ozempic and Wegovy, which are commonly used for weight loss and type 2 diabetes management.
A study led by Dr. Charles Taïeb, involving participants from France, the United States, Brazil, and Mexico, found a significant correlation between these medications and nail issues. Specifically, 39 percent of GLP-1 users reported onycholysis (the separation of the nail plate from the nail bed), compared to only 9 percent in a control group. Additionally, 46 percent of users reported nail discoloration, versus 17 percent in the control group. While researchers noted that many participants had existing nail issues prior to treatment, the frequency remained significantly higher among users even after accounting for rapid weight loss and nutritional deficiencies.
Separate research published in The BMJ by a team from the University of Pennsylvania suggests a potential link between GLP-1 medications and increased risks of alopecia (hair loss). While rapid weight loss is a suspected factor, researchers are investigating whether biological factors related to hereditary hair loss also play a role.
Entities
Charles Taïeb · European Academy of Dermatology and Venereology · GLP-1 medications · Ozempic · Science Alert · University of Pennsylvania · Wegovy
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] A study published in The BMJ suggests a link between GLP-1 medications and increased risk of hair loss (alopecia). www.braunschweiger-zeitung.de
- [● 4 SOURCES] A study led by Dr. Charles Taïeb found a potential link between GLP-1 medications and nail issues. www.harzkurier.de · www.ikz-online.de · www.otz.de · www.waz.de
- [● 4 SOURCES] 39 percent of GLP-1 users reported onycholysis (nail plate detachment) compared to 9 percent in the control group. www.harzkurier.de · www.ikz-online.de · www.otz.de · www.waz.de
- [● 4 SOURCES] Approximately half of the GLP-1 respondents already suffered from nail problems before starting treatment. www.harzkurier.de · www.ikz-online.de · www.otz.de · www.waz.de
- [● 4 SOURCES] 46 percent of GLP-1 users reported nail discoloration compared to 17 percent in the control group. www.harzkurier.de · www.ikz-online.de · www.otz.de · www.waz.de